Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia-Reperfusion Injury.
- DOI
- 10.3389/fcell.2020.621509
- Published
- 2020
- Container
- Frontiers in cell and developmental biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2020.621509,
title = {Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia-Reperfusion Injury.},
author = {Li T and Yin Y and Mu N and Wang Y and Liu M and Chen M and Jiang W and Yu L and Li Y and Ma H},
year = {2020},
journal = {Frontiers in cell and developmental biology},
doi = {10.3389/fcell.2020.621509},
url = {https://doi.org/10.3389/fcell.2020.621509}
}RIS
TY - JOUR TI - Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia-Reperfusion Injury. AU - Li T AU - Yin Y AU - Mu N AU - Wang Y AU - Liu M AU - Chen M AU - Jiang W AU - Yu L AU - Li Y AU - Ma H PY - 2020 JO - Frontiers in cell and developmental biology DO - 10.3389/fcell.2020.621509 UR - https://doi.org/10.3389/fcell.2020.621509 ER -
APA
T, L., Y, Y., N, M., Y, W., M, L., M, C., W, J., L, Y., Y, L., & H, M. (2020). Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia-Reperfusion Injury.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2020.621509
Source records
- pubmed · retrieved 2026-09-24T22:33:38.749Z